V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003005 | 10001940 | null | null | Palliative (P) | 2013-12-22 | 2014-01-07 | CARBOPLATIN + VINORELBINE | N | N | 10457283 | CARBOPLATIN + VINORELBINE |
| 10003006 | 10006328 | 1.74 | 63.8 | Palliative (P) | 2016-05-28 | 2016-06-04 | PEMBROLIZUMAB | N | N | 10457315 | PEMBROLIZUMAB |
| 10003007 | 10006328 | 1.62 | null | Neo-adjuvant (N) | 2016-02-21 | 2016-02-26 | ECX | N | N | 10457315 | ECX |
| 10003008 | 10006328 | null | null | Palliative (P) | 2017-10-10 | 2017-10-17 | PEMBROLIZUMAB | N | null | 10457315 | PEMBROLIZUMAB |
| 10003009 | 10006328 | 1.71 | 66.8 | Disease modification (D) | 2017-12-13 | 2017-12-26 | GO2 TRIAL | 1 | N | 10457315 | TRIAL |
| 10003010 | 10001941 | 1.69 | 64.7 | Curative (C) | 2018-11-17 | 2018-11-17 | Carboplatin + Vinorelbine Oral | N | N | 10457559 | CARBOPLATIN + VINORELBINE |
| 10003011 | 10001942 | 0 | 71.3 | Palliative (P) | 2018-11-05 | 2018-11-06 | CVP R | N | N | 10457575 | CVP R |
| 10003012 | 10001942 | null | 59.1 | Palliative (P) | 2016-08-08 | 2016-08-08 | PEMBROLIZUMAB | 02 | N | 10457575 | PEMBROLIZUMAB |
| 10003013 | 10001943 | 1.73 | 73.3 | Palliative (P) | 2013-10-16 | 2013-11-07 | PEMBROLIZUMAB | 2 | N | 10457792 | PEMBROLIZUMAB |
| 10003014 | 10001943 | 1.81 | 80.6 | null | 2017-01-03 | 2017-01-09 | Cisplatin + Pemetrexed | 02 | N | 10457792 | CISPLATIN + PEMETREXED |
| 10003015 | 10001943 | 1.75 | 62 | Curative (C) | 2016-07-02 | 2016-07-09 | EOX | 02 | N | 10457792 | EOX |
| 10003016 | 10001944 | 1.55 | null | Curative (C) | 2017-12-24 | 2018-01-10 | CISPLATIN + VINORELBINE | N | N | 10457990 | CISPLATIN + VINORELBINE |
| 10003017 | 10006331 | 1.68 | 93 | Palliative (P) | 2017-03-12 | 2017-03-22 | Carboplatin + Vinorelbine IV | 2 | N | 10458055 | CARBOPLATIN + VINORELBINE |
| 10003018 | 10006331 | 1.59 | 67 | Adjuvant (A) | 2018-09-21 | 2018-10-29 | Cisplatin + Vinorelbine (PO) | 02 | N | 10458055 | CISPLATIN + VINORELBINE |
| 10003019 | 10001945 | 1.68 | 73.3 | Curative (C) | 2017-12-20 | 2018-01-06 | ECX | 2 | N | 10458244 | ECX |
| 10003020 | 10001946 | 1.71 | 74.4 | Neo-adjuvant (N) | 2016-12-20 | 2016-12-21 | ECX | 02 | N | 10458254 | ECX |
| 10003021 | 10001946 | 1.78 | 81.5 | Palliative (P) | 2015-08-04 | 2015-08-04 | Hydroxycarbamide | N | N | 10458254 | HYDROXYCARBAMIDE |
| 10003022 | 10001947 | 1.48 | 62.1 | Disease modification (D) | 2018-12-09 | 2018-12-09 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 10458299 | RITUXIMAB |
| 10003023 | 10001948 | 1.67 | 70.35 | Adjuvant (A) | 2015-06-03 | 2015-06-28 | Cisplatin + Vinorelbine (IV) | 02 | null | 10458332 | CISPLATIN + VINORELBINE |
| 10003024 | 10001949 | 1.77 | null | Disease modification (D) | 2013-05-07 | 2013-05-09 | CVP R | 02 | N | 10458334 | CVP R |
| 10003025 | 10001950 | 1.62 | 55.4 | Adjuvant (A) | 2017-06-28 | 2017-07-04 | Cisplatin + Vinorelbine (PO) | 2 | N | 10458355 | CISPLATIN + VINORELBINE |
| 10003026 | 10001950 | 1.48 | 66.6 | Palliative (P) | 2016-07-10 | 2016-07-18 | PEMBROLIZUMAB | 2 | N | 10458355 | PEMBROLIZUMAB |
| 10003027 | 10001951 | 1.65 | 63.6 | Curative (C) | null | 2016-06-01 | ECX | 02 | N | 10458412 | ECX |
| 10003028 | 10001951 | null | null | Curative (C) | 2018-12-07 | 2019-01-20 | CVP R | null | N | 10458412 | CVP R |
| 10003029 | 10008044 | 1.86 | 93.6 | Disease modification (D) | 2016-08-07 | 2016-08-09 | Rituximab | N | N | 10458508 | RITUXIMAB |
| 10003030 | 10001952 | 1.77 | 86.4 | Neo-adjuvant (N) | 2018-08-23 | 2018-08-23 | CHEMO-T TRIAL | Y | N | 10458546 | TRIAL |
| 10003031 | 10001952 | 1.69 | 71 | Adjuvant (A) | 2016-12-31 | 2017-01-06 | CISPLATIN + VINORELBINE | N | null | 10458546 | CISPLATIN + VINORELBINE |
| 10003032 | 10001953 | 1.73 | 67.7 | Curative (C) | 2014-09-24 | 2014-09-25 | ECX | N | N | 10458635 | ECX |
| 10003033 | 10001954 | 0 | 61 | Palliative (P) | 2016-11-04 | 2016-11-12 | ECX | 02 | N | 10458641 | ECX |
| 10003034 | 10001955 | 1.67 | 46.3 | Palliative (P) | 2015-05-06 | 2015-05-14 | PEMBROLIZUMAB | N | N | 10458696 | PEMBROLIZUMAB |
| 10003035 | 10001956 | 1.68 | 63.3 | Palliative (P) | 2018-03-03 | 2018-03-03 | Enzalutamide | N | N | 10458718 | ENZALUTAMIDE |
| 10003036 | 10001956 | 1.65 | null | Palliative (P) | 2017-10-19 | 2017-11-04 | EOX | N | N | 10458718 | EOX |
| 10003037 | 10001956 | null | 51.5 | Curative (C) | 2016-08-08 | 2016-08-09 | Gemcitabine 1000mg/m2 D1 8 15 | null | N | 10458718 | GEMCITABINE |
| 10003038 | 10001957 | null | null | Palliative (P) | 2019-01-28 | 2019-02-04 | EOX | N | N | 10458786 | EOX |
| 10003039 | 10001958 | 1.7 | 89.9 | Palliative (P) | 2018-11-23 | 2018-11-27 | Enzalutamide | 02 | N | 10458875 | ENZALUTAMIDE |
| 10003040 | 10001959 | 1.69 | 0 | null | 2016-07-28 | 2016-07-28 | ECX | N | null | 10458916 | ECX |
| 10003041 | 10001959 | 1.57 | 60 | Palliative (P) | 2015-11-28 | 2015-12-11 | EOX | N | N | 10458916 | EOX |
| 10003042 | 10008046 | null | null | Palliative (P) | 2014-09-20 | 2014-09-25 | Carboplatin + Vinorelbine IV | N | N | 10458920 | CARBOPLATIN + VINORELBINE |
| 10003043 | 10001960 | 1.88 | 0 | Palliative (P) | 2015-02-23 | 2015-03-01 | PEMBROLIZUMAB | N | N | 10458940 | PEMBROLIZUMAB |
| 10003044 | 10006338 | 1.8 | null | Palliative (P) | 2015-01-30 | 2015-02-13 | Carboplatin + Vinorelbine Oral | 2 | N | 10458949 | CARBOPLATIN + VINORELBINE |
| 10003045 | 10008047 | null | null | null | 2018-12-21 | 2018-12-28 | CVP R | N | N | 10458958 | CVP R |
| 10003046 | 10008047 | 1.81 | 71 | Palliative (P) | 2018-05-28 | 2018-05-31 | Enzalutamide | 2 | N | 10458958 | ENZALUTAMIDE |
| 10003047 | 10001961 | 1.85 | 83.8 | Palliative (P) | 2015-06-22 | 2015-07-15 | Cisplatin + Pemetrexed | 02 | N | 10459130 | CISPLATIN + PEMETREXED |
| 10003048 | 10001962 | 1.57 | null | Neo-adjuvant (N) | 2016-05-21 | 2016-05-30 | Cisplatin + Vinorelbine (PO) | 02 | N | 10459206 | CISPLATIN + VINORELBINE |
| 10003049 | 10001963 | 1.77 | 51.3 | Curative (C) | 2017-11-26 | 2017-11-26 | Hydroxycarbamide | N | N | 10459218 | HYDROXYCARBAMIDE |
| 10003050 | 10001964 | 1.7 | 71 | Neo-adjuvant (N) | 2013-08-11 | 2013-08-11 | ECX | N | N | 10459233 | ECX |
| 10003051 | 10001964 | 1.7 | null | Palliative (P) | null | 2015-09-26 | GEMCITABINE | 02 | N | 10459233 | GEMCITABINE |
| 10003052 | 10001965 | 1.65 | 56.2 | Palliative (P) | 2015-09-10 | 2015-09-21 | PEMBROLIZUMAB | 2 | N | 10459240 | PEMBROLIZUMAB |
| 10003053 | 10001966 | 1.82 | 90 | Palliative (P) | 2018-03-11 | 2018-04-08 | Carboplatin + Vinorelbine Oral | 02 | N | 10459314 | CARBOPLATIN + VINORELBINE |
| 10003054 | 10001966 | 1.75 | 75 | Not known (9) | 2019-03-23 | 2019-03-25 | Enzalutamide | N | N | 10459314 | ENZALUTAMIDE |